ChemicalBook > CAS DataBase List > Tavilermide
Tavilermide
- Product Name
- Tavilermide
- CAS No.
- 263251-78-1
- Chemical Name
- Tavilermide
- Synonyms
- MIM-D3;Tavilermide;Glycine, N-(2-hydroxy-5-nitrobenzoyl)-L-α-glutamyl-L-lysyl-L-homoseryl-, cyclic (1→3)-ether;3-((4S,7S,10S)-7-(4-aminobutyl)-4-((carboxymethyl)carbamoyl)-14-nitro-6,9,12-trioxo-3,4,5,6,7,8,9,10,11,12-decahydro-2H-benzo[b][1,5,8,11]oxatriazacyclotetradecin-10-yl)propanoic acid;3-((4S,7S,10S)-7-(4-aminobutyl)-4-((carboxymethyl)carbamoyl)-14-nitro-6,9,12-trioxo-3,4,5,6,7,8,9,10,11,12-decahydro-2H-benzo[b][1,5,8,11]oxatriazacyclotetradecin-10-yl)propanoic acid(WXG02263)
- CBNumber
- CB13143877
- Molecular Formula
- C24H32N6O11
- Formula Weight
- 580.55
- MOL File
- 263251-78-1.mol
More
Less
Tavilermide Property
- Boiling point:
- 1122.4±65.0 °C(Predicted)
- Density
- 1.341±0.06 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- form
- Solid
- pka
- 3.59±0.10(Predicted)
- color
- White to off-white
- Water Solubility
- Water : 5 mg/mL (8.61 mM; adjust pH to 3-4 with HCl)
More
Less
N-Bromosuccinimide Price
ChemScene
- Product number
- CS-7495
- Product name
- Tavilermide
- Purity
- 99.62%
- Packaging
- 1mg
- Price
- $180
- Updated
- 2021/12/16
ChemScene
- Product number
- CS-7495
- Product name
- Tavilermide
- Purity
- 99.62%
- Packaging
- 5mg
- Price
- $540
- Updated
- 2021/12/16
ChemScene
- Product number
- CS-7495
- Product name
- Tavilermide
- Purity
- 99.62%
- Packaging
- 10mg
- Price
- $900
- Updated
- 2021/12/16
ChemScene
- Product number
- CS-7495
- Product name
- Tavilermide
- Purity
- 99.62%
- Packaging
- 50mg
- Price
- $2700
- Updated
- 2021/12/16
ChemScene
- Product number
- CS-7495
- Product name
- Tavilermide
- Purity
- 99.62%
- Packaging
- 100mg
- Price
- $3960
- Updated
- 2021/12/16
More
Less
Tavilermide Chemical Properties,Usage,Production
Biological Activity
Tavilermide is a selective TrkA partial agonist.
in vitro
Tavilermide (MIM-D3) is a tyrosine kinase TrkA receptor agonist, which can be used to treat dry eye. Tavilermide is a proteolytically stable, cyclic peptidomimetic that has been shown to be a partial TrkA receptor agonist. Tavilermide demonstrates activities similar to NGF (but does not bind to the p75NTR receptor) and can potentiate the effects of suboptimal concentrations of NGF.
target
TrkA
Tavilermide Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less